Background: Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) may reveal myocardial fibrosis which is associated with adverse clinical outcomes in patients undergoing implantable cardioverter-defibrillator (ICD) placement. At the same time, transmural LGE in the posterolateral wall is related to nonresponse to conventional cardiac resynchronization therapy (CRT). Herein, the aim was to assess the presence and determinants of LGE in CMR in heart failure (HF) with reduced ejection fraction. Methods: 67 patients were included (17.9% female, aged 45 [29-60] years), who underwent
INTRODUCTION
Appropriate patient evaluation for the placement of implantable cardioverterdefibrillators (ICD) and cardiac resynchronization therapy (CRT) devices is important in the management of heart failure (HF) patients with reduced ejection fraction (HFrEF). In patients with an ischemic or non-ischemic etiology of HF, left ventricular ejection fraction (LVEF) ≤ 35% continues to be used as a major criterion when considering patients for placement of an ICD in primary sudden cardiac death (SCD) prevention and to improve HF through CRT [1] .
However, effective SCD risk stratification based solely on HF symptoms and LVEF has a number of limitations. At the same time, about 30% of patients do not respond to CRT [2, 3] .
Cardiac magnetic resonance (CMR) imaging, especially with late gadolinium enhancement (LGE), is a valuable clinical tool in patients with left ventricular (LV) dysfunction [4, 5] . Gadolinium-based contrast agents accumulate and demonstrate delayed enhancement within areas of increased extracellular space such as fibrosis, thus enhancing areas of scarring [6] . The patterns of LGE help to differentiate between ischemic and nonischemic myocardial injury (Fig. 1A) . Generally, ischemic myocardial injury tends to cause
LGE this is typically subendocardial or transmural [7] . Non-ischemic myocardial injury can be observed at the epicardium, in the mid-wall, or at insertion points [5, 7, 8] . Moreover, LGE has been found to predict clinical outcomes in selected patients undergoing ICD placement [9] . At the same time, response to conventional CRT is decreased in the presence of transmural scarring in the posterolateral LV segments (the place over which an LV lead is usually placed) [10] .
The cardiac LV segmentation model published by the American Heart Association (AHA) divides the heart into 17 segments and is now widely used for the description of disease-affected myocardium [11] . These 17 segments have a reasonably consistent vascular supply from the main coronary arteries (Fig. 1B) . The left anterior descending coronary artery (LAD) supplies segments 1, 2, 7, 8, 13, 14 , and 17, the right coronary artery (RCA) supplies segments 3, 4, 9, 10, and 15, while the left circumflex coronary artery (LCx) supplies segments 5, 6, 11, 12, and 16 [11] . However, coronary arteries may be anomalous and their anatomy varies from patient to patient, creating a limitation of the AHA model [12] [13] [14] [15] .
The main purpose of this study was to assess the presence and determinants of LGE in CMR in patients with HFrEF.
METHODS

Study population
The study group included 67 patients (17.9% female, aged 45 years) who underwent LGE-CMR at the Department of Diagnostic Imaging, University Hospital in Krakow between 2011 and 2015, and had data available on LVEF as determined by echocardiography. Further data were obtained from a structured medical documentation review (baseline patient demographics and clinical data including chronic diseases).
Diagnosis of significant coronary artery disease (CAD) was based on coronary angiography (available in medical records of 36 patients) and was defined as coronary artery diameter stenosis of 50% or more, or previous cardiac revascularization (coronary angioplasty or coronary artery bypass grafting) [16] . Moreover, specifically a group of patients with LVEF ≤ 35% was addressed as determined by echocardiography, because they are frequently considered for ICD and CRT placement according to the European Society of Cardiology guidelines [17] . The study was approved by the local ethics committee.
CMR imaging
Cardiac magnetic resonance imaging was performed using a 1.5 Tesla scanner.
Steady-state free precession cine images were acquired in the short-axis and two-, three-, and four-chamber views. LGE images were acquired 10-20 min after injection of 0.2 mL/kg gadoteridol (ProHance). Inversion recovery time was individually adapted to maximize contrast between regions of LGE and normal myocardium. The cardiac LV segmentation model published by the AHA was used for the description of disease-affected myocardial segments [11] . The distribution of LGE was also assessed according to territories supplied by coronary arteries as proposed in the AHA model [11] . Posterolateral LV segments were defined as basal inferior [4] , basal inferolateral [5] , mid inferior [10] , and mid inferolateral [11] segments [10] . A transmural scar was defined as a hyperenhancement extending ≥ 51% of LV wall thickness in ≥ 1 of the LV segments [10] .
Statistical analysis
Continuous variables are presented as means ± standard deviations or medians (interquartile ranges [IQR]), while categorical variables are given as numbers and percentages. Associations between categorical variables were assessed using the Pearson chisquared test or the Fisher exact test. Continuous variables between two groups were compared using the Student t-test or Mann-Whitney U test, as appropriate. The Spearman rank test was used to measure the degree of association between two continuous variables (if both of the variables tested had a non-normal distribution). Statistical significance was defined as a p value < 0.05. Statistical analyses were performed using IBM SPSS Statistics (version 24, IBM Corp., Armonk, NY, USA).
RESULTS
Study population
Twenty nine patients were analyzed with HF and LVEF ≤ 35%, as determined by echocardiography, and 38 control patients with LVEF > 35%, also by echocardiography. LGE was observed. LVEF measured by echocardiography correlated with LVEF measured by CMR (R = 0.825, p < 0.001). Median LVEF measured by echocardiography was 47% (IQR 25-60%), while median LVEF measured by CMR was 44% (IQR 25-54%). Results of coronary angiography were available in medical documentation from the University Hospital for 36 patients. The median time interval between CMR and coronary angiography was 7 days (IQR 3-24 days).
Comparison of HF patients with LVEF of 35% or less and controls with LVEF > 35%
Among patients with HF and LVEF ≤ 35%, as determined by echocardiography, an ischemic pattern of LGE was observed in 15 (51.7%) subjects, non-ischemic in 10 (34.5%) patients, while 4 (13.8%) patients had no LGE. In controls, an ischemic pattern of LGE was observed in 9 (23.7%) subjects, non-ischemic in 16 (42.1%), combined ischemic and nonischemic or a non-specific pattern in 6 (15.8%), while 7 (18.4%) had no LGE.
There was no significant difference regarding the presence of LGE of any pattern between HF patients with LVEF ≤ 35% when compared to controls. However, the ischemic pattern of LGE was more prevalent in HF patients with LVEF ≤ 35% when compared to controls (Table 1) . Moreover, in the first group of patients, transmural LGE was observed more frequently when compared with the remainder of the patients (44.8% vs. 13.2%, p = 0.004). The presence of LGE of any pattern was observed more frequently in patients with LVEF ≤ 35% than in controls in the mid and apical third (75.9% vs. 44.7%, p = 0.01; 51.7% vs. 26.3%, p = 0.033; respectively), while there was no difference in observed LGE in the basal third between these two groups ( Table 2) . Interestingly, in the mid third LGE was observed more commonly in segments 8, 10, and 12, while in the apical third LGE was observed more commonly in segments 13, 15, and 16 in HF patients with LVEF ≤ 35% than in the control group (Table 2 ).
In patients for whom coronary angiography data were available (n = 36) there was a trend towards a higher prevalence of CAD in HF patients with LVEF ≤ 35% than the remainder of the patients (63.6% vs. 35 .7%, p = 0.102; Table 3 ). When individual coronary arteries were analyzed, only the LCx was more commonly affected by significant CAD in HF patients with LVEF ≤ 35% when compared to controls (50.0% vs. 7.1%, p = 0.011). At the same time, when LGE was assessed in segments according to coronary artery distribution, there was a trend to more commonly observed LGE in segments supplied by the LAD in HF patients with LVEF ≤ 35% than in controls (68.2% vs. 35 .7%, p = 0.056; Table 3 ).
Assessment of HF patients with LVEF of 35% or less with or without LGE
The vast majority of studied HF patients with LVEF ≤ 35% had observed LGE (n = 25, 86.2%). LGE in HF patients with LVEF ≤ 35% was associated with CAD (68.0% vs. 0.0%, p = 0.02), while only trends were observed for its association with older age and previous myocardial infarction (MI) (54.4 ± 13.4 vs. 41.0 ± 16.2, p = 0.08 and 48.0% vs. 0.0%, p = 0.12, respectively).
Patients with LVEF ≤ 35% and transmural LGE were older than the remainder of HF patients with LVEF ≤ 35% and no transmural LGE (60.1 ± 7.6 vs. 46.5 ± 15.7, p = 0.006; Table 4 ). CAD, MI, and the ischemic pattern of LGE were observed more commonly in patients with LVEF ≤ 35% and transmural LGE when compared with the remainder of patients with LVEF ≤ 35% and no transmural LGE (92.3% vs. 31.3%, p = 0.001; 84.6% vs. 6.3%, p < 0.001; 100.0% vs. 12.5%, p < 0.001, as in Table 4 ).
In HF patients with LVEF ≤ 35%, transmural LGE in the posterolateral wall (31%) was associated with older age, CAD, and previous MI (60.6 ± 6.3 vs. 49.0 ± 15.6 years, p = 0.008, 100% vs. 40%, p = 0.003 and 77.8% vs. 25%, p = 0.014, respectively, Table 4 ). In a group of patients with LVEF ≤ 35% and transmural LGE in the posterolateral LV segments, the presence of an ischemic pattern of LGE was more prevalent when compared with the remaining HF patients with LVEF ≤ 35% and no observed transmural LGE in this region (100% vs. 30%, p = 0.001, Table 4 ).
Patients with LVEF ≤ 35% and observed LGE in any LV segment from the posterolateral wall were older than patients with LVEF ≤ 35% and had no observed LGE in this region (61.5 ± 9.3 vs. 44.3 ± 13.2, p < 0.001). Among patients with LVEF ≤ 35% and observed LGE in any LV segment from the posterolateral wall, CAD was more frequently present than in the remaining patients with LVEF ≤ 35% and no observed LGE in this region (85.7% vs. 33.3%, p = 0.004; Table 5 ). The ischemic pattern of LGE was more common in patients with LGE in the posterolateral LV wall than in the group without LGE in this region (78.6% vs. 26.7%, p = 0.005). Transmural LGE of any type was observed more commonly in HF patients with LGE in the posterolateral LV wall than in those without LGE in this region (71.4% vs. 20.0%, p = 0.005, Table 5 ).
Comparison of patients with ischemic vs. non-ischemic pattern of LGE
When patients with an ischemic (n = 24) vs. non-ischemic pattern (n = 26) of LGE were compared, CAD, previous MI, and dyslipidemia were more common in those with the ischemic pattern of LGE (Table 5 ). Patients with an ischemic pattern of LGE were more commonly admitted urgently to the hospital and had observed akinesia more commonly in CMR (79.2% vs. 46.2%, p = 0.016; 41.7% vs. 15.4%, p = 0.039, Table 5 ) when compared to patients with a non-ischemic LGE pattern. Interestingly, in all patients with an ischemic pattern of LGE (n = 24), LGE was observed more commonly only in apical segments when compared to patients with a non-ischemic pattern (70.8% vs. 30.8%, p = 0.005). Moreover,
LGE of any pattern in the posterolateral wall was observed more commonly in patients with an ischemic LGE pattern when compared to patients with a non-ischemic LGE pattern (66.7% vs. 34.6%, p = 0.024). Similarly, transmural LGE, including that in the posterolateral wall, was observed more commonly in the first group when compared to the second group (Table   5) Table 5 ).
DISCUSSION
Cardiac magnetic resonance is the most accurate non-invasive method to evaluate myocardial necrosis and fibrosis, which helps in the identification of the underlying cause of LV dysfunction, and may provide important prognostic information [18] [19] [20] [21] . Previous studies have shown the usefulness of CMR imaging qualitative assessment in the diagnostics of CAD [21] [22] [23] . It has been suggested that LGE may be useful in excluding significant CAD in some patients with new-onset LV dysfunction in whom there is no data suggestive of ischemic disease [22] . An analysis of LGE distribution is also valuable when differentiating between non-ischemic etiologies of LV dysfunction including dilated cardiomyopathy, cardiac sarcoidosis, myocarditis, hypertrophic cardiomyopathy, cardiac amyloidosis, and Anderson-Fabry disease [6] . However, it should be highlighted that an LGE pattern is not always specific for a particular disease and the inclusion of clinical information is crucial in the diagnostic process.
Patient-specific coronary supply territories may be derived from magnetic resonance angiography, and these territories sometimes differ from those defined by the AHA model of coronary blood supply, which suggests that the 17-segmented model proposed by the AHA may be inaccurate [12, 24] . A greater prevalence of significant CAD in the LCx and more frequent LGE in segments supplied by the LAD in HF patients with LVEF ≤ 35%,has been observed. This highlights the potential discrepancies between coronary territories determined by coronary angiography and the presence of LGE on CMR. Moreover, this study suggests that LVEF as measured in CMR, but not in echocardiography, may be associated with patterns of LGE. Previous studies have shown a strong relationship between myocardial fibrosis and worsening of HF [25] [26] [27] . In patients with muscular dystrophy, Florian et al. [28] found a correlation between LVEF and LGE extent and a relationship between the LGE pattern and degree of LV systolic dysfunction. However, several studies involving patients with non-ischemic cardiomyopathy showed only a weak or no relationship between the presence of LGE or LGE volume and LV volume and function [29] [30] [31] [32] .
LGE-CMR imaging could also be useful in the assessment of patients who meet criteria for CRT since absence of LGE is associated with greater CRT response [10] . Previous studies have found a significant correlation between total scar burden and non-response to CRT, and have proposed a dose-response type relationship in these groups, which may predict this outcome [33, 34] . A recent study including patients with dilated cardiomyopathy and CRT found that CRT-defibrillators provided a survival benefit over CRT-pacemakers only in patients with observed LGE [35] . Moreover, implantation of an LV lead over an area with transmural myocardial scarring may result in an ineffective CRT [10] . Thus, clinical determinants of transmural scarring in posterolateral LV segments were also searched for as its identification may lead to a qualification of patients to other forms of physiologic cardiac pacing, including His or para-His pacing, which would avoid potentially adverse outcomes related to right ventricular pacing [36] . Findings herein, suggest that clinical variables (older age, CAD, and previous MI) are associated with transmural posterolateral LGE.
Cardiovascular risk stratification is important and could be improved by the use of biomarkers or data from Holter electrocardiogram recordings [37] [38] [39] . Some studies have demonstrated that the presence of LGE predicts poor clinical outcomes such as hospitalization due to HF, fatal ventricular arrhythmias, and SCD, in patients with either an ischemic or nonischemic etiology of HF [8, 26, [40] [41] [42] [43] [44] . Non-ischemic HF etiology is one of the predictors of LVEF recovery [45] . However, a recently adjusted analysis has shown that major nonischemic fibrosis was related to worse clinical outcomes than MI [8] . The presence of LGE was found to be associated with appropriate ICD therapy. Among patients with dilated cardiomyopathy and LVEF ≤ 35%, ICD implantation was associated with a reduction in mortality only among those with LGE [9] . Thus, the present study is important as it explores the determinants of LGE presence. It was found that CAD is associated with LGE in HF patients with LVEF ≤ 35%, while previous MI and older age have a tendency to be associated with LGE in these patients. This is in line with observations by other investigators who demonstrated that the presence of LGE was significantly higher in patients with CAD.
Moreover, they suggested that CMR is useful for classification of patients with new-onset HF and LV systolic dysfunction in relation to the presence or absence of CAD [22, 23] . LGE-CMR imaging may provide independent prognostic information beyond LVEF. Thus, the analysis of LGE distribution may improve patient selection and scheduling for standard ICD implantation in primary prevention of SCD. The association between LGE and ventricular arrhythmias was observed both in studies on patients with mean LVEF ≤ 35% and in those with mean LVEF > 35% [43] . Importantly, many SCD occur in patients with EF > 35% [46] . Therefore, it may be hypothesized that patients with prevalent LGE and EF > 35% could also benefit from primary SCD prevention with ICD placement.
Limitations of the study
There are some limitations in this study. The current study is a retrospective analysis and includes a relatively small group of patients. There is potential over-representation of non-ischemic HF etiologies in the present cohort due to typical clinical scenarios in which CMR is most commonly used in clinical practice. Information on coronary angiography results was not available for all patients in their medical documentation. Coronary angiography and CMR were not always performed within few days apart. However, the median time interval between these studies was relatively short at 7 days (IQR 3-24 days).
Detailed indications for the use of LGE-CMR before potential cardiovascular implantable electronic device implantation remain to be established in large prospective studies. 
Figure 1.
The patterns of late gadolinium enhancement reflecting ischemic and non-ischemic myocardial injury (A) and assignment of the 17 myocardial segments to the territories of the coronary arteries (B). Based on references [7, 11] ; LADleft anterior descending coronary artery; LCxleft circumflex coronary artery; LGElate gadolinium enhancement; RCA right coronary artery.
